Follow Us -

September 05, 2026

RPG Life Sciences Eyes Larger API Acquisitions After ₹215 Crore Deals; ₹500 Crore+ Capital in Hand

Pharma major steps up its buy-and-build strategy, targeting differentiated chemistry, regulatory capabilities, international customers and export opportunities Mumbai: RPG Life Sciences is stepping up its expansion in the Active Pharmaceutical Ingredients (API) business and is scouting for larger acquisition opportunities after committing
September 5, 2026

Categories